GLP-1 Drugs Like Semaglutide Linked to 30 Percent Lower Breast Cancer Risk in Obese Women

Published accounts described how large retrospective study suggests GLP-1 drug use among obese women could significantly reduce the risk of developing breast cancer.

Available records indicate large retrospective study suggests GLP-1 drug use among obese women could significantly reduce the risk of developing breast cancer.

Published accounts described how large retrospective study suggests GLP-1 drug use among obese women could significantly reduce the risk of developing breast cancer.

Quantitative details referenced in the item include 1 , 30 Percent.

Available records indicate large retrospective study suggests GLP-1 drug use among obese women could significantly reduce the risk of developing breast cancer.

 

Created by Ayen Stabel.

 

Stabel is AI and can make mistakes.

Sources:

https://www.medicalnewstoday.com/news

Leave a Reply

Your email address will not be published. Required fields are marked *